Nuclear Medicine
The Nuclear Medicine Department was established in 1999. It is a key clinical specialty of Guangdong Province and a project unit of Shenzhen’s Three Projects in nuclear medicine. It is a Peking University nuclear-medicine specialist training base, a national standardized resident-training base and the Shenzhen Nuclear Medicine Quality Control Center. In the 2023 China Hospital Science and Technology Value (STEM) ranking, it ranked 60th nationally among nuclear-medicine specialties; in the 2023 Fudan University South China nuclear-medicine reputation ranking, it ranked tenth. It has 4 high-level talents in Shenzhen, 2 elite talents of the Health Commission and 1 backbone talent, and is a master’s training site for Guangdong Medical University, Shenzhen University, Shantou University and Southern University of Science and Technology. Current research includes National Natural Science Foundation, provincial/ministerial and departmental/bureau projects, with research funding exceeding 9 million yuan. It is a standing-committee unit of the Nuclear Medicine Physicians Branch of the Chinese Medical Doctor Association (also leading its functional group), deputy-chair unit of the Big Data and Artificial Intelligence Working Committee of the Nuclear Medicine Branch of the Chinese Medical Association, deputy-chair unit of the Nuclear Medicine Branch of the Guangdong Medical Doctors Association and the Nursing Association, and a standing-committee unit of the Nuclear Medicine Branch of the Guangdong Medical Association. The department has advanced domestic molecular-diagnostic imaging equipment, including GE DMI PET/CT and DISCOVERY NM670 SPECT/CT. It performs PET/CT and SPECT/CT examinations, nuclear-medicine outpatient services, radionuclide applicator therapy, and iodine-131 treatment for hyperthyroidism and thyroid cancer, with more than 20,000 outpatient visits annually.